| ¿µ¹® | basal layer of skin | ÇÑ±Û | ±âÀúÃþ |
|---|---|---|---|
| ¼³¸í | Ç¥ÇÇÀÇ °¡Àå ¾Æ·¡ ºÎºÐÀÌ¸ç ¼¼Æ÷ÀÇ ¸ð¾çÀÌ ºñ±³Àû Á÷»ç°¢Çü¿¡ °¡±õ°í ÀÏÁ¤ÇÑ ¹è¿À» ÇÑ´Ù. |
||
| ¿µ¹® | skin tag | ÇÑ±Û | ÁãÁ¥, ÇǺο¬¼º¼¶À¯Á¾ |
|---|---|---|---|
| ¼³¸í | ÁÖ·Î ¸ñ, °Üµå¶ûÀÌ, ´Ù¸®¿¡ »ý±â´Â »ì»ö ¶Ç´Â °ú»ö¼Ò Ä§Âø¼ºÀÇ ÀÛÀº ¸ñÀ» °¡Áø ¼¶À¯¼º µ¹Ãâ¹°·Î ´ë°³ ¹«Áõ»óÀÌ´Ù. |
||
| ¿µ¹® | skin | ÇÑ±Û | ÇǺΠ|
|---|---|---|---|
| ¼³¸í | ½Åü¸¦ ½Î°í ÀÖ´Â ¹Ù±ùÃþÀ¸·Î¼ Ç¥ÇÇ, ÁøÇÇ, ÇÇÇÏÁ¶Á÷À¸·Î ±¸¼ºµÇ¸ç, ¿ÜºÎ ȯ°æÀ¸·ÎºÎÅÍ ½Åü¸¦ º¸È£Çϰí ü¿ÂÀ» Á¶ÀýÇÏ´Â ±â´ÉÀ» °¡Áü. 1.Ç¥ÇÇ: ÇǺÎÀÇ °¡Àå ¹Ù±ùÃþÀ¸·Î¼ ¿Ü¹è¿±¿¡¼ ±â¿øÇÏ¸ç °¢ÁúÀ̶ó´Â ±¸Á¶ ´Ü¹éÁúÀ» »ý»êÇÏ´Â ±â´ÉÀ» °¡Áü. 4°¡ÁöÀÇ ¼¼Æ÷°¡ Àִµ¥, °¢Áú¼¼Æ÷, ¸á¶ó´Ñ¼¼Æ÷, Langerhans ¼¼Æ÷, ºÎÁ¤Çü ¼¼Æ÷, Merkel¼¼Æ÷°¡ ÀÖ´Ù. Ç¥ÇÇ¿¡´Â ÀÌ 4°¡Áö ¼¼Æ÷¿Ü¿¡ ´ÙÀ½°ú °°Àº Ç¥ÇÇ ºÎ¼Ó±â°¡ ÀÖ´Ù. ¿¡Å©¸° ¶¡»ù(eccrine sweat gland): Á¡¸· ÇǺΠ°æ°è ºÎÀ§ µî Ư¼öÇÑ ºÎÀ§¸¦ Á¦¿ÜÇÑ ¸ðµç ÇǺο¡¼ ¹ß°ßµÇ¸ç ¶¡À» ºÐºñÇÏ´Â »ùÀ¸·Î¼ ½Åü ¿ Á¶Àý ü°èÀÇ Áß¿äÇÑ ¿ä¼Ò. ¾ÆÆ÷Å©¸°»ù(apocrine gland): °Üµå¶ûÀÌ, Á¥²ÉÆÇ, Ç×¹® »ý½Ä±â ºÎÀ§, ¿ÜÀ̵µ, ´«²¨Ç® µî¿¡¼¸¸ ¹ß°ßµÇ¸ç ºÐºñ¹°ÀÇ ±â´ÉÀº Àß ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ¸³ª µ¿¹°¿¡¼´Â ¹æ¾î ¹× ¼ºÀû ±â´ÉÀÌ ÀÖÀ½. ÅÐÁÖ¸Ó´Ï(hair follicle): ¼Õ¹Ù´Ú, ¹ß¹Ù´Ú µî Ư¼ö ºÎÀ§¸¦ Á¦¿ÜÇÑ ½Åü Àü ºÎÀ§¿¡ ºÐÆ÷Çϸç Àΰ£¿¡¼ Áß¿äÇÑ »ý¸®Àû ±â´ÉÀº ¾øÀ¸³ª ¼ºÀû ¸Å·ÂÀ» Áö´Ï´Â ½Åü Àå½ÄÀÇ ±â´ÉÀ» °¡Áü. ±â¸§»ù(sebaceous gland): ¼Õ¹Ù´Ú°ú ¹ß¹Ù´ÚÀ» Á¦¿ÜÇÑ Àü ÇǺο¡ ºÐÆ÷ÇÏ¸ç ºÐºñ¹°À» ±â¸§(sebum)¶ó ºÎ¸§. ³²¼º È£¸£¸óÀÇ Àڱؿ¡ ÀÇÇØ ¼ºÀåÇÏ¸ç »ý¸®Àû ±â´ÉÀº Àß ¾Ë·ÁÁ® ÀÖÁö ¾ÊÀ½. ¼Õ¹ßÅé(nail) 2. ÁøÇÇ: Ç¥ÇÇ ¾Æ·¡¿¡ Á¸ÀçÇÏ´Â Á߹迱 ±â¿øÀÇ Á¶Á÷À¸·Î¼ Ç÷°ü, ¸²ÇÁ°ü, ½Å°æ, ±ÙÀ°, Ç¥ÇÇ ºÎ¼Ó±â µîÀ» Æ÷ÇÔÇϰí ÀÖÀ½. Ç¥ÇÇ ¹Ù·Î ¹ØÀÇ ºÎÀ§¸¦ À¯µÎ ÁøÇǶó ÇÏ°í ¾Æ·¡ÃþÀ» ¸Á»ó ÁøÇǶó ÇÑ´Ù. Á¶Á÷ ¼¶À¯¿¡´Â ¾Æ±³Áú ¼¶À¯, ±×¹° ¼¶À¯, ź·Â ¼¶À¯ÀÇ ¼¼ Á¾·ù°¡ ÀÖ´Ù. 3. ÇÇÇÏ Á¶Á÷: ÁøÇÇ ¾Æ·¡¿¡ Á¸ÀçÇϸç Á߹迱 ±â¿øÀ¸·Î¼ º¸¿Â ÀÛ¿ë, Ãæ°Ý Èí¼ö ÀÛ¿ë, ¿µ¾ç ÀúÀå ÀÛ¿ëÀÇ ±â´ÉÀÌ ÀÖ´Ù. |
||
| ¿µ¹® | skin dose | ÇÑ±Û | ÇǺμ±·® |
|---|---|---|---|
| ¼³¸í | 1. ÇǺÎÇ¥¸é¿¡¼ÀÇ ¹æ»ç¼±ÀÇ °øÁß¼±·®À¸·Î ¿©±â¿¡´Â 1Â÷¹æ»ç¼±°ú ÈĹæ»ê¶õÀÌ Æ÷ÇԵȴÙ. 2. ÇǺο¡ Èí¼öµÇ´Â ¼±·®. |
||
| SD | Sandhoff disease; senile dementia; septal defect; serologically defined; serologically detectable; s... |
|---|---|
| SSA | salicylsalicylic acid; sicca syndrome A; skin-sensitizing antibody; skin sympathetic activity; Sjogr... |
| ST | esotropia; scala tympani; scaphotrapezoid; sclerotherapy; sedimentation time; semitendinosus; sensor... |
| STD | selective T-cell defect; sexually transmitted disease; skin-to-tumor distance; skin test dose; sodiu... |
| JP drain | The original suction drain. The drain itself is inside the body. It is made of Teflon and has multip... |
| DRO | Differential Reinforcement of Other Behaviour |
|---|---|
| MOTT | Mycobacteria Other Than Tuberculosis |
| OND | Other Neurological Diseases |
| SO | significant other |
| AOD | and other drug |
| other-directed | Pertaining to a person readily influenced by the attitudes of others. (05 Mar 2000) |
|---|---|
| transferases (other substituted phosphate groups) | <enzyme> A class of enzymes that transfers substituted phosphate groups. Registry number: EC 2.7.8 (12 Dec 1998) |
| attachment sites | <microbiology, molecular biology> Particular loci in both bacterial and phage DNA molecules at which phage DNA is integrated into the bacterial DNA by recombination between these sites. (12 Dec 1998) |
| binding sites | The reactive parts of a macromolecule that directly participate in its specific combination with another molecule. (12 Dec 1998) |
| binding sites, antibody | Local surface sites on antibodies which react with antigen determinant sites on antigens. They are formed from parts of the variable regions of the fab fragment of the immunoglobulin. (12 Dec 1998) |
| chromosome fragile sites | Heritable sensitive regions of chromosomes which show up in vitro as non-staining bands. They are associated with chromosome breakage and other aberrations, and, when located on sex chromosomes, they produce phenotypic abnormalities. No abnormal phenotype has been definitely identified with autosomal fragile sites, but some rare autosomal recessive disorders may be due to homozygosity for fragile sites. Fragile sites are designated by the letters "fra" followed by the designation for the specific chromosome and locus. (12 Dec 1998) |
| contact sites A | Developmentally regulated adhesion sites that appear on the ends of aggregation competent Dictyostelium discoideum at the stage when the starved cells begin to come together to form the grex. Originally detected by the use of Fab fragments of polyclonal antibodies, raised against aggregation competent cells and adsorbed against vegetative cells, to block adhesion in EDTA containing medium. (Cell cell adhesion mediated by contact sites A, unlike that mediated by contact sites B, is not divalent cation sensitive). The fact that a mutant deficient in csA behaves perfectly normally in culture is puzzling. (18 Nov 1997) |
| contact sites B | Developmentally regulated adhesion sites that appear on the ends of aggregation competent Dictyostelium discoideum at the stage when the starved cells begin to come together to form the grex. Originally detected by the use of Fab fragments of polyclonal antibodies, raised against aggregation competent cells and adsorbed against vegetative cells, to block adhesion in EDTA containing medium. (Cell cell adhesion mediated by contact sites A, unlike that mediated by contact sites B, is not divalent cation sensitive). The fact that a mutant deficient in csA behaves perfectly normally in culture is puzzling. (18 Nov 1997) |
| crohn disease: sites | <radiology> Oesophagus: rare, stomach (2-20%): granulomatous gastritis, pseudo-post Bilroth-I appearance, ramshorn sign, antral-duodenal fistula, duodenum (4-10%): almost always associated with gastric involvement, bulb and proximal half of duodenum, small bowel (80%): regional enteritis, terminal ileum (alone/in combination): 95%, jejunum/ileum: 15%, commonly associated with medial caecal defect, colon (22-55%): granulomatous colitis, particularly on the right side, transverse stripe sign: contrast within coarse mucosal folds, rectum (35-50%) see: Crohn disease (12 Dec 1998) |
| sequence tagged sites | Short, tagged tracts of DNA sequence that are used as landmarks in genome mapping. In most instances, 200 to 500 base pairs of sequence define a sequence tagged site (sts) that is operationally unique in the human genome (i.e., can be specifically detected by the polymerase chain reaction in the presence of all other genomic sequences). The overwhelming advantage of stss over mapping landmarks defined in other ways is that the means of testing for the presence of a particular sts can be completely described as information in a database. (12 Dec 1998) |
| sequence-tagged sites | Short stretches of DNA sequences that can be detected by use of the polymerase chain reaction. (05 Mar 2000) |
| immunologically privileged sites | Sites where allografts are not readily rejected, probably because these particular areas have poor lymphatic drainage. (05 Mar 2000) |
| abscess, skin | Medical term for a common boil. (12 Dec 1998) |
| allergy skin test | Test done on the skin to identify the allergy substance (allergen) triggering the allergic reaction. A small amount of the suspected allergy substance is placed on the skin. The skin is then gently scratched through the small drop with a special sterile needle. If the skin reddens and, more importantly, swells, then allergy to that substance is probable. (12 Dec 1998) |
| alligator skin | <dermatology> A group of cutaneous disorders characterised by increased or aberrant keratinisation, resulting in noninflammatory scaling of the skin. Many different metaphors have been used to describe the appearance and texture of the skin in the various types and stages of ichthyosis, for example alligator, collodion, crocodile, fish and porcupine skin. most ichthyoses are genetically determined, while some may be acquired and develop in association with various systemic diseases or be a prominent feature in certain genetic syndromes. The term is commonly used alone to refer to i. Vulgaris. (18 Nov 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|